Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Technologies
Worthington, Minnesota, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Cambridge Technologies operates a USDA-licensed custom (autogenous) vaccine and diagnostics business for production animals, using next-generation sequencing and molecular diagnostics to identify herd-specific pathogens and manufacture fully customized bacterial and viral vaccines for bovine, swine, poultry and small ruminants.[1][2]
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologic
- Industry
- Veterinary
02
Partnerships
Merck Animal Health (agreement to provide autogenous vaccines to the U.S. poultry industry, with Cambridge providing production expertise and distribution and Merck Animal Health providing commercial reach).[2]
Beyond the preview
Go deeper on Cambridge Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cambridge Technologies.